GOLDENWELL BIOTECH, INC. GWLL
OTC · stock · Food and Kindred Products · website · IPO 2021-12-07
GOLDENWELL BIOTECH, INC. financials (annual, from 10-K)
Bars are annual figures from 2019 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | $139 | $2,340 | $47,800 | $15,967 | $0 | $0 |
| Gross profit | $64 | $666 | $25,186 | $8,388 | $0 | $0 |
| SG&A expense | — | — | — | $126,655 | $6,368 | $2,601 |
| Operating income | -$123,098 | -$115,826 | -$985,105 | -$118,267 | — | — |
| Interest expense | $8,400 | $1,535 | — | $0 | $0 | $0 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$131,498 | -$117,361 | -$985,097 | -$116,981 | -$6,324 | -$2,311 |
| EPS (diluted) | $0.00 | $0.00 | — | — | — | — |
| Operating cash flow | -$123,077 | -$113,153 | -$1.1M | -$205,138 | -$6,324 | -$2,311 |
| Cash & equivalents | — | $53,231 | $45,996 | $213,556 | $248,569 | $246,593 |
| Inventory | $174,788 | $174,863 | $176,058 | $198,671 | $0 | — |
| Total assets | $224,192 | $228,094 | $248,400 | $460,979 | $248,569 | $246,593 |
| Total liabilities | $271,433 | $143,837 | $46,782 | $159,266 | $0 | $0 |
| Shareholders' equity | -$47,241 | $84,723 | $201,618 | $301,713 | $248,569 | $246,593 |
Growth · year-over-year
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue growth | -94.1% | -95.1% | +199.4% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001800373 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.